Literature DB >> 16731413

Vulvar ulcers in young females: a manifestation of aphthosis.

Jill S Huppert1, Michael A Gerber, Helen R Deitch, Joel E Mortensen, Mary Allen Staat, Paula J Adams Hillard.   

Abstract

STUDY
OBJECTIVE: To examine the etiology, clinical course, and outcomes of non-sexually transmitted vulvar ulcers in young females.
DESIGN: A prospective cohort study of subjects referred to a tertiary center who had active vulvar ulcers and no evidence of sexually transmitted infections were evaluated with a structured clinical and laboratory protocol and followed with visits or telephone calls.
RESULTS: Twenty eligible subjects had a mean age of 14 years (range 10-19), and five were premenarchal. Nineteen reported systemic symptoms such as fever, malaise, and headache. Most ulcers were >1cm in diameter (range 0.3-5 cm) and were located on the medial aspect of the labia minora. All viral, bacterial, and fungal cultures were negative. Serologic testing for Epstein-Barr virus (EBV) infection demonstrated 10 subjects with evidence of prior infection, two with acute infection, one indeterminate, and seven negative for infection. Two subjects had evidence of possible acute cytomegalovirus (CMV) infection. Other laboratory findings were nonspecific. The median duration of pain was 10 days (range 6-30), and 75% healed by 21 days. Follow up was available for 19 subjects (median 14 months). Seven experienced recurrent ulcers 2-16 months after the initial episode, and 10 had experienced oral aphthous ulcers. None met criteria for other etiologies of vulvar ulcers reported in the literature.
CONCLUSIONS: No single infectious agent was identified as a cause of vulvar ulcers. Most cases were not temporally associated with either acute EBV or CMV infection. These ulcers are consistent with aphthous major or complex aphthosis that arise in response to acute illness.

Entities:  

Mesh:

Year:  2006        PMID: 16731413     DOI: 10.1016/j.jpag.2006.02.006

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  9 in total

1.  Lipschütz ulcer and group A streptococcal tonsillitis.

Authors:  Sara Limão; Ana Ventura; Gustavo Queirós; Florbela Cunha
Journal:  BMJ Case Rep       Date:  2018-06-06

2.  Genitourinary manifestations of epstein-barr virus infections.

Authors:  Randi Leigh; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

3.  Acute genital ulcers.

Authors:  Silvia Delgado-García; Ana Palacios-Marqués; Juan Carlos Martínez-Escoriza; Tina-Aurora Martín-Bayón
Journal:  BMJ Case Rep       Date:  2014-01-28

4.  Reactive non-sexually related acute genital ulcers associated with COVID-19.

Authors:  Jill M Krapf; Rachel K Casey; Andrew T Goldstein
Journal:  BMJ Case Rep       Date:  2021-05-05

5.  Ulcus vulvae acutum - A case of genital ulcers in adolescent girl.

Authors:  Daniela Visentin; Lorenza Driul; Cinzia Buligan; Ayuna Angarkhayeva; Caterina Pinzani; Monica Della Martina; Ambrogio Londero; Giuseppe Stinco
Journal:  Case Rep Womens Health       Date:  2015-12-11

6.  Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 Vaccination.

Authors:  Anna V Wojcicki; Katherine L O'Flynn O'Brien
Journal:  J Pediatr Adolesc Gynecol       Date:  2021-10-25       Impact factor: 1.814

7.  Vulvar Aphthous Ulcers in an Adolescent After Coronavirus Disease 2019 (COVID-19) Vaccination.

Authors:  Stephen M Scott; Veronica Alaniz; Leslie Appiah; Eliza Buyers; Carri Holton; Patricia Huguelet
Journal:  Obstet Gynecol       Date:  2022-08-03       Impact factor: 7.623

8.  Fournier's Gangrene Associated with Local Cutaneous HPV Lesions in a Previously Healthy Girl.

Authors:  Maria Tsinti; Theophani Tsekoura; Evangelos Blevrakis; Ioannis Vlachakis; Amalia Tsilimigaki-Christaki
Journal:  Case Rep Pediatr       Date:  2013-04-22

9.  Adolescents with Vulvar Ulcers: COVID-19 disease, COVID-19 Vaccines, and the Value of Case Reports.

Authors:  Jill Huppert
Journal:  J Pediatr Adolesc Gynecol       Date:  2022-01-31       Impact factor: 1.814

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.